Truist Securities analyst Bertrand Donnes initiated coverage on BKV Corporation (NYSE:BKV) with a Buy rating and a price ...

Truist analyst Bertrand Donnes initiated coverage of BKV Corp. (BKV) with a Buy rating and $24 price target The SMID-cap energy company has ...

Analysts at KeyCorp issued their Q3 2024 earnings estimates for shares of BKV in a research note issued to investors on ...

KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 ...

Fintel reports that on October 25, 2024, Truist Securities initiated coverage of BKV (NYSE:BKV) with a Buy recommendation.

BKV Corporation (NYSE:BKV – Get Free Report) has been given an average recommendation of “Buy” by the eight analysts that are currently covering the firm, Marketbeat.com reports. Eight analysts have ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

KeyBanc analyst Tim Rezvan maintained a Buy rating on BKV Corporation (BKV – Research Report) today. The company’s shares closed last Friday at $18.45. According to TipRanks, Rezvan is an ...

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 billion. The beginning of the U ...

Investing.com -- KeyBanc Capital Markets initiated coverage of BKV Corp. (NYSE:BKV) with an "overweight" rating and set a price target of $23 per share. The analysts see BKV as a unique player in ...

Sept 26 (Reuters) - Shares of BKV (BKV.N), opens new tab rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market capitalization of $1.56 ...